Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Oncogene
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 


9 December 2002, Volume 21, Number 56

Table of Contents

< Previous    Issue    Next >

CML: Molecular Mechanisms & Therapeutic Strategies

Guest Editor Dr Ralph B Arlinghaus

Guest Editor
Ralph Arlinghaus FREE
Abstract  |  Full text  |  PDF 8535
Philadelphia-positive leukemia: a personal perspective FREE
Nora Heisterkamp & John Groffen
Abstract  |  Full text  |  PDF 8536
Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML FREE
Brian J Druker
Abstract  |  Full text  |  PDF 8541
BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia FREE
Stephanie Salesse & Catherine M Verfaillie
Abstract  |  Full text  |  PDF 8547
Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia FREE
Ralph B Arlinghaus
Abstract  |  Full text  |  PDF 8560
Transforming pathways activated by the v-Abl tyrosine kinase FREE
Scott K Shore, Ramana V Tantravahi & E Premkumar Reddy
Abstract  |  Full text  |  PDF 8568
Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins FREE
Danilo Perrotti & Bruno Calabretta
Abstract  |  Full text  |  PDF 8577
Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571 FREE
Ramadevi Nimmanapalli & Kapil Bhalla
Abstract  |  Full text  |  PDF 8584
BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability FREE
Tomasz Skorski
Abstract  |  Full text  |  PDF 8591
Mechanisms underlying abnormal trafficking and expansion of malignant progenitors in CML: BCR/ABL-induced defects in integrin function in CML FREE
Stephanie Salesse & Catherine M Verfaillie
Abstract  |  Full text  |  PDF 8605
The biology of chronic myelogenous leukemia:mouse models and cell adhesion FREE
Jason A Wertheim, Juli P Miller, Lanwei Xu, Yiping He & Warren S Pear
Abstract  |  Full text  |  PDF 8612
The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model FREE
Ruibao Ren
Abstract  |  Full text  |  PDF 8629
Studying the pathogenesis of BCR-ABL+ leukemia in mice FREE
Richard A Van Etten
Abstract  |  Full text  |  PDF 8643
BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations FREE
Fabrizio Pane, Mariano Intrieri, Concetta Quintarelli, Barbara Izzo, Giada Casadei Muccioli & Francesco Salvatore
Abstract  |  Full text  |  PDF 8652
The basis of T-cell-mediated immunity to chronic myelogenous leukemia FREE
Jeffrey J Molldrem, Shreya Kant, Weidong Jiang & Sijie Lu
Abstract  |  Full text  |  PDF 8668
9 December 2002, Volume 21, Number 56
< Previous    Issue    Next >
Privacy Policy © 2002 Nature Publishing Group